| 000 | 01431 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514010215.0 | ||
| 264 | 0 | _c20010920 | |
| 008 | 200109s 0 0 eng d | ||
| 022 | _a0161-6420 | ||
| 024 | 7 |
_a10.1016/s0161-6420(01)00657-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDoan, S | |
| 245 | 0 | 0 |
_aTreatment of ocular cicatricial pemphigoid with sulfasalazine. _h[electronic resource] |
| 260 |
_bOphthalmology _cSep 2001 |
||
| 300 |
_a1565-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadverse effects |
| 650 | 0 | 4 |
_aAutoimmune Diseases _xdrug therapy |
| 650 | 0 | 4 | _aBlood Cell Count |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 |
_aConjunctivitis _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPemphigoid, Benign Mucous Membrane _xdrug therapy |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aSulfasalazine _xadverse effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aLerouic, J F | |
| 700 | 1 | _aRobin, H | |
| 700 | 1 | _aProst, C | |
| 700 | 1 | _aSavoldelli, M | |
| 700 | 1 | _aHoang-Xuan, T | |
| 773 | 0 |
_tOphthalmology _gvol. 108 _gno. 9 _gp. 1565-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0161-6420(01)00657-1 _zAvailable from publisher's website |
| 999 |
_c11459167 _d11459167 |
||